Abvc Biopharma (ABVC) Prepaid Assets (2010 - 2026)
Abvc Biopharma's (ABVC) quarterly Prepaid Assets came in at $250017.0 in Q1 2026, up 159.46% YoY from $96362.0 in Q1 2025, and down 27.87% on a QoQ basis from $346616.0 in Q4 2025.
Abvc Biopharma (ABVC) Prepaid Assets (2010 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has 13 years of Prepaid Assets data on file, last reported at $250017.0 in Q1 2026.
- Quarterly Prepaid Assets rose 159.46% year-over-year to $250017.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $250017.0 (up 159.46% YoY) and the FY2025 annual result came in at $346616.0, up 260.26% from the prior year.
- Prepaid Assets retreated to $250017.0 in Q1 2026, from $346616.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.3 million in Q2 2022 to a low of $96213.0 in Q4 2024.
- A 5-year average of $309348.9 and a median of $219645.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 88.63% — and 2025, when it surged 291.49%.
- Tracing ABVC's Prepaid Assets over 5 years: stood at $150235.0 in 2022, then sank by 32.74% to $101051.0 in 2023, then declined by 4.79% to $96213.0 in 2024, then surged by 260.26% to $346616.0 in 2025, then retreated by 27.87% to $250017.0 in 2026.
- The last three Prepaid Assets figures came in at $250017.0 (Q1 2026), $346616.0 (Q4 2025), and $447280.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 151,559.00 |
| Mar 31, 2026 | 250,017.00 |
| Dec 31, 2025 | 346,616.00 |
| Sep 30, 2025 | 447,280.00 |
| Jun 30, 2025 | 194,999.00 |
| Mar 31, 2025 | 96,362.00 |
| Dec 31, 2024 | 96,213.00 |
| Sep 30, 2024 | 114,251.00 |
| Jun 30, 2024 | 219,645.00 |
| Mar 31, 2024 | 383,309.00 |
| Dec 31, 2023 | 101,051.00 |
| Sep 30, 2023 | 143,127.00 |
| Jun 30, 2023 | 148,024.00 |
| Mar 31, 2023 | 347,852.00 |
| Dec 31, 2022 | 150,235.00 |
| Sep 30, 2022 | 287,181.00 |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 631,321.00 |
| Dec 31, 2021 | 528,354.00 |
| Sep 30, 2021 | 815,916.00 |